News

Biotech & Pharma Business
Rigel completes VEPPANU licensing deal with Arvinas and Pfizer
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Cystic Fibrosis Foundation backs SpliSense with up to $13m to advance SPL84 Phase 2b study
read more
Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Mabion revives MabionCD20 through rare disease collaboration with Oddifact
read more
Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Innovative Molecules adds Epstein-Barr virus antiviral programme to pipeline
read more
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics
Poolbeg secures European patent decision for POLB 001 in cytokine release syndrome
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Confo Therapeutics reports preclinical data for post-bariatric hypoglycaemia candidate at ENDO 2026
read more
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
CERo Therapeutics reports Phase 1 CER-1236 update with AML patient proceeding to stem cell transplant
read more
Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Lonza licenses dual-payload ADC technology to Antharis for GI cancers
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Grifols launches Fesilty in US for congenital fibrinogen deficiency
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
NICE recommends pirtobrutinib for relapsed chronic lymphocytic leukaemia
read more
Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain
Cellares secures $50M investment to expand automated cell therapy manufacturing
read more
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics
Faeth Therapeutics focuses on PIKTOR as oncology Phase 2 data nears
read more
Biotech & Pharma Business,Drug Discovery & Development
ZoBio launches DNA-encoded library hit discovery service for difficult drug targets
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Elicio misses Phase 2 endpoint but advances Phase 3 plan for pancreatic cancer immunotherapy
read more
Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Context reports 29% response rate for CTIM-76 in platinum-resistant ovarian cancer
read more
Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain
VIVEbiotech expands in vivo lentiviral vector portfolio to 15 programmes
read more

Rigel completes VEPPANU licensing deal with Arvinas and Pfizer

Cystic Fibrosis Foundation backs SpliSense with up to $13m to advance SPL84 Phase 2b study

Mabion revives MabionCD20 through rare disease collaboration with Oddifact

Innovative Molecules adds Epstein-Barr virus antiviral programme to pipeline

Poolbeg secures European patent decision for POLB 001 in cytokine release syndrome

Confo Therapeutics reports preclinical data for post-bariatric hypoglycaemia candidate at ENDO 2026

CERo Therapeutics reports Phase 1 CER-1236 update with AML patient proceeding to stem cell transplant

Lonza licenses dual-payload ADC technology to Antharis for GI cancers

Grifols launches Fesilty in US for congenital fibrinogen deficiency

NICE recommends pirtobrutinib for relapsed chronic lymphocytic leukaemia

Cellares secures $50M investment to expand automated cell therapy manufacturing

Faeth Therapeutics focuses on PIKTOR as oncology Phase 2 data nears

ZoBio launches DNA-encoded library hit discovery service for difficult drug targets

Elicio misses Phase 2 endpoint but advances Phase 3 plan for pancreatic cancer immunotherapy

Context reports 29% response rate for CTIM-76 in platinum-resistant ovarian cancer

VIVEbiotech expands in vivo lentiviral vector portfolio to 15 programmes

main menu

recent posts

Autolomous and Cellular Origins integrate platforms for cell therapy manufacturing

Alamar launches blood-based eMTBR-Tau assay for Alzheimer’s disease research

Bio-Rad launches Vericheck ddPCR kits for cell and gene therapy quality control

get connected